Sanofi
-
Sanofi, GSK kick off Phase III trial for Covid-19 shot
France's Sanofi and Britain's GlaxoSmithKline launched a late-stage human trial
-
Sanofi eyes approval of Covid-19 vaccine by first half of 2021
Company says it has the capacity to produce up to 1 billion doses a year of its recombinant vaccine
-
Children present their take on healthy lifestyles through art
Sanofi Pakistan organised an art contest as part of its diabetes awareness programme
-
Sanofi’s new insulin provides diabetes control
The new insulin promises stable blood sugar control throughout the day and night
-
New insulin effective for 24 hours launched in Pakistan
Insulin Glargine U300 promises stable blood sugar control throughout the day and night
-
How Sanofi's setback could lead to better dengue vaccines
Dengue is the world’s fastest-growing infectious disease, afflicting up to 100 million people worldwide
-
Philippines orders probe into vaccine, Sanofi says no deaths reported
Evidence shows it can worsen the disease in people not previously exposed to the infection
